US equities |
GOOGL $324.89 ▲+0.00% GOOG $321.89 ▲+0.00% MU $983.23 ▲+0.00% LITE $913.95 ▲+0.00% MSFT $531.01 ▲+0.00% SNDK $1,404.77 ▲+0.00% MRVL $251.65 ▲+0.00% SKHY $164.70 ▲+0.00%
FinancialContent

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration
Tags iShares Biotechnology ETF Bristol/Myers Squibb Co Eli Lilly and Co
From CNBC.com News
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
Tags Eli Lilly and Co Health & Science Health care industry
From CNBC.com News
Hantavirus outbreak isn't another Covid pandemic – but experts say it's testing U.S. readiness
Tags Biotech and Pharmaceuticals Business Pharmaceuticals
From CNBC.com News
Healthy Returns: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight
Tags Health & Science Social issues Novo Nordisk A/S
From CNBC.com News
Cramer's lightning round: Buy Caterpillar
Tags Nokia Corp stocks U/S/ Markets
From CNBC.com News
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk
Tags Social issues Healthy Returns Novo Nordisk A/S
From CNBC.com News
Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
Tags Health & Science Mergers Health care industry
From CNBC.com News
Wegovy sales smash forecasts after pill launch as Novo Nordisk hikes guidance
Tags Biotechnology Novo Nordisk A/S Breaking News: Europe
From CNBC.com News
Iran tensions, Palantir earnings, Musk's SEC settlement and more in Morning Squawk
Tags Eli Lilly and Co Investing Politics
From CNBC.com News
Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly's GLP-1 dominance
Tags Eli Lilly and Co Health & Science LifeMD Inc
From CNBC.com News
'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds
Tags US: News Spdr S&P Biotech Etf Novo Nordisk A/S
From CNBC.com News
Weight loss and hair loss: The growing hair treatment market from GLP-1s
Tags Retail Health care industry Novo Nordisk A/S
From CNBC.com News
Apple earnings, DHS shutdown, 'Ozempic breath' and more in Morning Squawk
Tags Markets Alphabet Class A Investment strategy
From CNBC.com News
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Tags UnitedHealth Group Inc Novo Nordisk A/S Healthy Returns
From CNBC.com News
Trump fires Fed's Cook, Musk sues Apple and OpenAI, Netflix's theatrical run and more in Morning Squawk
Tags Netflix Inc Markets Eli Lilly and Co
From CNBC.com News
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Tags Novo Nordisk A/S Health care industry Breaking News: Business
From CNBC.com News
A world on weight loss drugs: How GLP-1s are reshaping the economy
Tags Food and drink Health & Science Danone SA
From CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Tags Biotechnology AstraZeneca PLC Breaking News: Business
From CNBC.com News
CNBC's UK Exchange newsletter: The price is REIT
Tags CNBC UK Exchange Real estate Europe News
From CNBC.com News
FDA approves first-ever glucose monitoring system for weight loss from Signos
Tags Biotech and Pharmaceuticals Business Pharmaceuticals
From CNBC.com News
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
Tags Biotechnology Health care industry Novo Nordisk A/S
From CNBC.com News
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Tags Business News Breaking News: Business Novo Nordisk A/S
From CNBC.com News
'Don't quit the market' when it's frothy, says Jim Cramer. Here's why
Tags Oklo Inc Investment Strategy Circle Internet Group Inc
From CNBC.com News
Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs
Tags Health care industry Breaking News: Business Biotechnology
From CNBC.com News
Cramer's Lightning Round: Affirm is a buy
Tags Stock Picks Mad Money Eli Lilly and Co
From CNBC.com News
5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista
Tags Technology McDonald's Corp United Airlines Holdings Inc
From CNBC.com News
Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
Tags Breaking News: Business Health care industry Biotechnology
From CNBC.com News
Eli Lilly's obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval
Tags Biotech and Pharmaceuticals Pharmaceuticals Business
From CNBC.com News
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
Tags AstraZeneca PLC CVS Health Corp Novo Nordisk A/S
From CNBC.com News
5 things to know before the Monday open: Berkshire's tariff fears | Ethereum turns 10 | Restaurants embrace spicy
Tags CAVA Group Inc Eli Lilly and Co Business
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >